HRB Clinical Research Facility Cork
Welcome to the Health Research Board Clinical Research Facility, Cork (CRF-C) a collaboration between University College Cork and the Health Research Board. The Facility’s administrative centre and its Adult Research Unit are located in the Mercy University Hospital and the Paediatric Discovery Unit is based on the Cork University Hospital Campus. The Research Support Hub maintains a variety of research offices and units located throughout UCC and its affiliated hospitals, which cover the southern and south-western part of the Republic of Ireland with a total catchment area of almost 1 million subjects.
The purpose of the CRF-C is to provide the dedicated infrastructure, experienced research and support staff and the necessary quality and oversight programs that are critical for the successful conduct of world-class patient -focused research.
Our vision is to position UCC at the forefront of patient-focused research within Ireland and to enhance its international reputation for research excellence. We aim to promote excellence in the efficient and cost effective design, conduct, analysis and teaching of patient focused research and to mitigate to the fullest extent possible all elements of risk associated with such research.
The CRF-C supports a wide range of Academic and Commercially funded research, including both interventional trials and observation studies, across pharmaceutical, neutriceutical, medical device and care pathway themes.
The staff at the CRF-C are happy to guide your study from the conceived idea through funding application, sponsorship, regulatory and ethical submission, data collection, analysis, reporting and dissemination. Grow your research at the CRF-C. For further information on the facilities, support and expertise available at the CRF-C please contact us at email@example.com or 353 (0) 21 4935150.
The Quality and Regulatory Department of the Clinical Research Facility-Cork at the HRB-Clinical Research Facility, UCC will be running a free workshop on Pharmacovigilance for HPRA Regulated IMP Studies.